UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European urology, ISSN 0302-2838, 2016, Volume 70, Issue 6, pp. 1080 - 1081
Journal Article
European urology, ISSN 0302-2838, 12/2016, Volume 70, Issue 6, p. 1080
Journal Article
European urology, ISSN 0302-2838, 09/2020, Volume 78, Issue 3, pp. 470 - 471
Journal Article
European urology, ISSN 0302-2838, 10/2019, Volume 76, Issue 4, pp. 538 - 539
Journal Article
European urology, ISSN 0302-2838, 04/2019, Volume 75, Issue 4, pp. 697 - 698
Journal Article
The Journal of urology, ISSN 0022-5347, 09/2020, Volume 204, Issue 3, pp. 510 - 510
Journal Article
European urology, ISSN 0302-2838, 08/2020, Volume 78, Issue 2, pp. 291 - 292
Journal Article
European urology, ISSN 0302-2838, 2017, Volume 72, Issue 3, pp. 470 - 471
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 15, pp. 1408 - 1418
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prostate-Specific Antigen | Double-Blind Method | Humans | Middle Aged | Proportional Hazards Models | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Prostatic Neoplasms, Castration-Resistant - pathology | Disease-Free Survival | Thiohydantoins - adverse effects | Exanthema - chemically induced | Neoplasm Metastasis - prevention & control | Thiohydantoins - therapeutic use | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Prostate cancer | Care and treatment | Metastasis | Medical research | Antigens | Lymphatic system | Medical imaging | Prostate-specific antigen | Research & development--R&D | Family medical history | Hypothyroidism | Survival | Patients | Metastases | Androgens | Hospitals | Castration | Prostate | Index Medicus | Abridged Index Medicus | Adenocarcinoma | pathology | Androgen Antagonists | Exanthema | 80 and over | Prostatic Neoplasms | Neoplasm Metastasis | Thiohydantoins | Urologi och njurmedicin | drug therapy | chemically induced | Castration-Resistant | prevention & control | secondary | adverse effects | Urology and Nephrology | therapeutic use
Journal Article
The Journal of nuclear medicine (1978), ISSN 0161-5505, 05/2020, Volume 61, Issue 5, pp. 678 - 682
Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Antigens | Medical imaging | Laboratories | Health services | Medical treatment | Positron emission | Clinical trials | Imaging techniques | Criteria | Metastases | Magnetic resonance imaging | Computed tomography | Biopsy | Tomography | Biomarkers | Lesions | Bone imaging | Prostate cancer | Prostate | Cancer | Index Medicus | progression | prostate cancer | PSMA | Theranostics | 3P | PET
Journal Article
European urology, ISSN 0302-2838, 05/2019, Volume 75, Issue 5, pp. 875 - 875
Journal Article
The Journal of urology, ISSN 0022-5347, 2017, Volume 198, Issue 3, pp. 575 - 582
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2017, Volume 58, Issue 8, pp. 1207 - 1209
Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Diagnostic Imaging | Glutamate Carboxypeptidase II - metabolism | Humans | Antigens, Surface - metabolism | Prostatic Neoplasms, Castration-Resistant - therapy | Male | Prostatic Neoplasms, Castration-Resistant - diagnostic imaging | Molecular Targeted Therapy | Prostatic Neoplasms, Castration-Resistant - metabolism | Urologists | Index Medicus
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 03/2018, Volume 59, Issue 3, pp. 469 - 478
Criteria | Interpretation | PSMA-ligand PET/CT | miTNM | PROMISE | Standardized evaluation | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Reference Standards | Glutamate Carboxypeptidase II - metabolism | Humans | Gene Expression Regulation, Neoplastic | Image Interpretation, Computer-Assisted | Prostatic Neoplasms - diagnostic imaging | Ligands | Male | Neoplasm Staging | Positron Emission Tomography Computed Tomography - standards | Medical personnel | Antigens | Medical research | Nuclear magnetic resonance--NMR | Physicians | Positron emission | Clinical trials | Studies | Magnetic resonance imaging | Computed tomography | Imaging | Tomography | Prostate cancer | Prostate | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1767 - 1777
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biopsy - methods | Prostatic Neoplasms - pathology | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ultrasonography, Interventional | Male | Biopsy - adverse effects | Magnetic Resonance Imaging | Prostate - pathology | Prostate - diagnostic imaging | Intention to Treat Analysis | Prostatic Neoplasms - diagnostic imaging | Quality of Life | Surveys and Questionnaires | Aged | Quality Control | Usage | Magnetic resonance imaging | Biopsy | Men | Diagnosis | Health aspects | Prostate cancer | Medical research | Nuclear magnetic resonance--NMR | Prostate-specific antigen | Urology | Ultrasonic imaging | Hospitals | Risk assessment | Ultrasonography | Prostate | Index Medicus | Abridged Index Medicus | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Radiologi och bildbehandling | Medicin och hälsovetenskap | Radiology, Nuclear Medicine and Medical Imaging | Klinisk medicin | Cancer and Oncology | Urology and Nephrology | Cancer och onkologi
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2019, Volume 145, Issue 2, pp. 531 - 539
renal cell carcinoma | serum | plasma | IMP3 | prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Viral antibodies | RNA | Analysis | Antibodies | Carcinoma, Renal cell | Metastasis | Enzyme-linked immunosorbent assay | Cell survival | Gene expression | Tissues | Risk analysis | Survival | Blood levels | Metastases | Proteins | Medical prognosis | Kidney cancer | Plasma levels | Clear cell-type renal cell carcinoma | Tumors | Index Medicus
Journal Article
The Journal of urology, ISSN 0022-5347, 2011, Volume 185, Issue 4, pp. e419 - e419
Journal Article
BJU international, ISSN 1464-4096, 11/2017, Volume 120, Issue 5, pp. 631 - 638
prostate biopsy | magnetic resonance imaging | prostate cancer | image fusion | transperineal biopsy | PCSM | prostate‐specific antigen density | ProstateCancer | prostate-specific antigen density | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Predictive Value of Tests | Prostatic Neoplasms - pathology | Prospective Studies | Humans | Middle Aged | Magnetic Resonance Imaging, Interventional - statistics & numerical data | Ultrasonography, Interventional - statistics & numerical data | Male | Prostatic Neoplasms - epidemiology | Image-Guided Biopsy - statistics & numerical data | Prostate - pathology | Prostate - diagnostic imaging | Prostatic Neoplasms - diagnostic imaging | Aged | Medicine, Experimental | Medical research | Care and treatment | Biopsy | Prostate cancer | Prostate | Ultrasonic imaging | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Benign | Ultrasound | Index Medicus
Journal Article